
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; font-size: 12px; }
        tr:nth-child(even) { background-color: #f9f9f9; }
        th { background-color: #3366CC; color: white; font-weight: bold; }
        h2 { color: #4F81BD; border-bottom: 2px solid #4F81BD; padding-bottom: 5px;}
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: small; color: grey;"><i>Page 30 of 119</i></p>
<p style="font-size: small; color: grey;"><i>Abbott_Laboratories_10k_030.pdf</i></p>
<p>A comparison of significant product and product group sales is as follows. Percent changes are versus the prior year and are based on unrounded numbers.</p>

<table>
	<tr>
		<th>(dollars in millions)</th>
		<th>2017</th>
		<th>Total Change</th>
		<th>Impact of Exchange</th>
		<th>Total Change Excl. Exchange</th>
	</tr>
	<tr>
		<td>Total Established Pharmaceuticals</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Key Emerging Markets</td>
		<td>$ 3,307</td>
		<td>14%</td>
		<td>2%</td>
		<td>12%</td>
	</tr>
	<tr>
		<td>Other</td>
		<td>980</td>
		<td>3</td>
		<td>1</td>
		<td>2</td>
	</tr>
	<tr>
		<td>Nutritionals</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>International Pediatric Nutritionals</td>
		<td>2,112</td>
		<td>(4)</td>
		<td>—</td>
		<td>(4)</td>
	</tr>
	<tr>
		<td>U.S. Pediatric Nutritionals</td>
		<td>1,777</td>
		<td>6</td>
		<td>—</td>
		<td>6</td>
	</tr>
	<tr>
		<td>International Adult Nutritionals</td>
		<td>1,782</td>
		<td>3</td>
		<td>(1)</td>
		<td>4</td>
	</tr>
	<tr>
		<td>U.S. Adult Nutritionals</td>
		<td>1,254</td>
		<td>(3)</td>
		<td>—</td>
		<td>(3)</td>
	</tr>
	<tr>
		<td>Diagnostics -</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Core Laboratory</td>
		<td>4,063</td>
		<td>6</td>
		<td>—</td>
		<td>6</td>
	</tr>
	<tr>
		<td>Molecular</td>
		<td>463</td>
		<td>2</td>
		<td>1</td>
		<td>1</td>
	</tr>
	<tr>
		<td>Point of Care</td>
		<td>550</td>
		<td>7</td>
		<td>—</td>
		<td>7</td>
	</tr>
	<tr>
		<td>Rapid Diagnostics</td>
		<td>540</td>
		<td>n/m</td>
		<td>n/m</td>
		<td>n/m</td>
	</tr>
	<tr>
		<td>Cardiovascular and Neuromodulation</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Rhythm Management</td>
		<td>2,103</td>
		<td>n/m</td>
		<td>n/m</td>
		<td>n/m</td>
	</tr>
	<tr>
		<td>Electrophysiology</td>
		<td>1,382</td>
		<td>n/m</td>
		<td>n/m</td>
		<td>n/m</td>
	</tr>
	<tr>
		<td>Heart Failure</td>
		<td>643</td>
		<td>n/m</td>
		<td>n/m</td>
		<td>n/m</td>
	</tr>
	<tr>
		<td>Vascular</td>
		<td>2,892</td>
		<td>14</td>
		<td>—</td>
		<td>14</td>
	</tr>
	<tr>
		<td>Structural Heart</td>
		<td>1,083</td>
		<td>208</td>
		<td>1
</td>
		<td>207</td>
	</tr>
	<tr>
		<td>Neuromodulation</td>
		<td>808</td>
		<td>n/m</td>
		<td>n/m</td>
		<td>n/m</td>
	</tr>
</table>
<p>n/m = Percent change is not meaningful.</p>

<table>
	<tr>
		<th>(dollars in millions)</th>
		<th>2016</th>
		<th>Total Change</th>
		<th>Impact of Exchange</th>
		<th>Total Change Excl. Exchange</th>
	</tr>
	<tr>
		<td>Total Established Pharmaceuticals</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Key Emerging Markets</td>
		<td>$ 2,912</td>
		<td>5%</td>
		<td>(8)%</td>
		<td>13%</td>
	</tr>
	<tr>
		<td>Other</td>
		<td>947</td>
		<td>1</td>
		<td>(1)</td>
		<td>2</td>
	</tr>
	<tr>
		<td>Nutritionals -</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>International Pediatric Nutritionals</td>
		<td>2,206</td>
		<td>(7)</td>
		<td>(4)</td>
		<td>(3)</td>
	</tr>
	<tr>
		<td>U.S. Pediatric Nutritionals</td>
		<td>1,677</td>
		<td>5</td>
		<td>—</td>
		<td>5</td>
	</tr>
	<tr>
		<td>International Adult Nutritionals</td>
		<td>1,724</td>
		<td>—</td>
		<td>(4)</td>
		<td>4</td>
	</tr>
	<tr>
		<td>U.S. Adult Nutritionals</td>
		<td>1,292</td>
		<td>1</td>
		<td>—</td>
		<td>1</td>
	</tr>
	<tr>
		<td>Diagnostics</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Core Laboratory</td>
		<td>3,844</td>
		<td>4</td>
		<td>(2)</td>
		<td>6</td>
	</tr>
	<tr>
		<td>Molecular</td>
		<td>456</td>
		<td>(2)</td>
		<td>(1)</td>
		<td>(1)</td>
	</tr>
	<tr>
		<td>Point of Care</td>
		<td>513</td>
		<td>8</td>
		<td>—</td>
		<td>8</td>
	</tr>
	<tr>
		<td>Rapid Diagnostics</td>
		<td>—</td>
		<td>—</td>
		<td>—
</td>
		<td>—</td>
	</tr>
	<tr>
		<td>Cardiovascular and Neuromodulation</td>
		<td></td>
		<td></td>
		<td></td>
		<td></td>
	</tr>
	<tr>
		<td>Rhythm Management</td>
		<td>—</td>
		<td>—
</td>
		<td>—</td>
		<td>—</td>
	</tr>
	<tr>
		<td>Electrophysiology</td>
		<td>12</td>
		<td>(17)</td>
		<td>—</td>
		<td>(17)</td>
	</tr>
	<tr>
		<td>Heart Failure</td>
		<td>—</td>
		<td>—</td>
		<td>—</td>
		<td>—</td>
	</tr>
	<tr>
		<td>Vascular</td>
		<td>2,532</td>
		<td>1</td>
		<td>—
</td>
		<td>1</td>
	</tr>
	<tr>
		<td>Structural Heart</td>
		<td>352</td>
		<td>35</td>
		<td>(1)</td>
		<td>36</td>
	</tr>
	<tr>
		<td>Neuromodulation</td>
		<td>—</td>
		<td>—</td>
		<td>—</td>
		<td>—</td>
	</tr>
</table>
<p>Note: In order to compute results excluding the impact of exchange rates, current year U.S. dollar sales are multiplied or divided, as appropriate, by the current year average foreign exchange rates and then those amounts are multiplied or divided, as appropriate, by the prior year average foreign exchange rates.</p>
<p style="font-size: small; color: grey;"><i>29</i></p>
<p style="font-size: small; color: grey;"><i>file://usmdcvdi003.us.kworld.kpmg.com/GDC_Ops/Operations/Gayathri%20Krishnan/RPA%20Phase%20II/Kiran/HealthCare/ ... 7/23/2018</i></p>

</body>
</html>
